Superbugs Be Gone

Kastus CEO John Browne (center) at Kastus Technologies, which announced a breakthrough formula to control superbugs. (Photo: Shane O'Neill Photography)

By Adam Farley, Deputy Editor
August / September 2017

Dublin Institute of Technology start-up company Kastus was the recent recipient of a Knowledge Transfer Ireland award, which promotes publicly-funded research in Ireland, for their new antimicrobial solution designed to kill so-called “superbugs” like MRSA, Ecoli, fungus associated with athlete’s foot, and carbapenem-resistant enterobacteriaceae.

Kastus CEO John Browne says their solution will kill what the World Health Organization calls the “Dirty Dozen,” twelve superbugs listed as highest priority, including critical bugs like acineto- bacter, pseudomonas, and various enterobacteriaceae.

­According to Marie O’Halloran, a health reporter for the Irish Times, “These can cause bloodstream infections and pneumonia and pose a major risk in hospitals and nursing homes. The W.H.O. list also includes high- and medium-priority drug-resistant bacteria that cause diseases such as gonorrhea and food poisoning caused by salmonella.”

The solution is “factory applied,” according to Brown, mixed in with raw materials during the manufacturing process, allowing the solution to infuse just about any product imaginable, from smartphones to door knobs, ATMs to ceramics. Buoyed by patent success in America and the U.K., Kastus has fifteen other global patents pending for their solution. ♦

Leave a Reply




Share



More Articles

Growing Unrest in
Northern Ireland

April 17, 2021 By Deaglán de Bréadún Concern has been growing in Ireland, north and south, that the Troubles...

More

Joe Biden in Carlingford, Co. Lough, June 25, 2016. Photo: Rollingnews.ie
NEWS FROM IRELAND:
The U.S. Election, Brexit, and Handling the Pandemic

By Deaglán de Bréadún On a happy note, there has been a general welcome in the Republic and among...

More

News from Ireland:
October / November 2019

The latest goings on. ℘℘℘ Ireland is particularly exposed to economic turbulence from a no-deal...

More

Dr. Kevin Tracey in the lab at Northwell Health System's Feinstein Institute for Medical Research in Manhasset, NY.
Dr. Kevin J. Tracey: Inventing the Future of Medicine

Dr. Kevin J. Tracey, president & CEO of the Feinstein Institutes, is a trailblazer in the neuroscience of immunity,...

More